In this regard, the retrospective study by Karakus et al. [127] demonstrated that tirzepatide, in addition to AID, led to significant improvement of glucose control, reduction of TDD of insulin, and weight loss among adult patients with T1D and obesity. This evidence concerns the gene INS and Obesity.